A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

February 28, 1997

Conditions

Sarcoma, KaposiHIV Infections

Interventions

DRUG

TNP-470

Trial Locations (6)

Northwestern University CRS, Chicago

USC CRS, Los Angeles

Bmc Actg Crs, Boston

Beth Israel Deaconess - East Campus A0102 CRS, Boston

Washington U CRS, St Louis

Beth Israel Med. Ctr. (Mt. Sinai), New York

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000763 - A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter